JP7340572B2 - 酸化マグネシウム錠剤 - Google Patents

酸化マグネシウム錠剤 Download PDF

Info

Publication number
JP7340572B2
JP7340572B2 JP2021134883A JP2021134883A JP7340572B2 JP 7340572 B2 JP7340572 B2 JP 7340572B2 JP 2021134883 A JP2021134883 A JP 2021134883A JP 2021134883 A JP2021134883 A JP 2021134883A JP 7340572 B2 JP7340572 B2 JP 7340572B2
Authority
JP
Japan
Prior art keywords
cellulose
tablet
magnesium oxide
less
tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021134883A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023028906A (ja
Inventor
徹 山地
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SETOLAS Holdings Inc
Original Assignee
SETOLAS Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2021134883A priority Critical patent/JP7340572B2/ja
Application filed by SETOLAS Holdings Inc filed Critical SETOLAS Holdings Inc
Priority to PCT/JP2022/030484 priority patent/WO2023022078A1/ja
Priority to EP22858399.3A priority patent/EP4389133A4/en
Priority to CN202280056422.3A priority patent/CN117835990A/zh
Priority to US18/685,051 priority patent/US20250127725A1/en
Priority to TW111130617A priority patent/TW202322827A/zh
Publication of JP2023028906A publication Critical patent/JP2023028906A/ja
Priority to JP2023087784A priority patent/JP2023099857A/ja
Application granted granted Critical
Publication of JP7340572B2 publication Critical patent/JP7340572B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2021134883A 2021-08-20 2021-08-20 酸化マグネシウム錠剤 Active JP7340572B2 (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP2021134883A JP7340572B2 (ja) 2021-08-20 2021-08-20 酸化マグネシウム錠剤
EP22858399.3A EP4389133A4 (en) 2021-08-20 2022-08-09 MAGNESIUM OXIDE TABLETS
CN202280056422.3A CN117835990A (zh) 2021-08-20 2022-08-09 氧化镁片剂
US18/685,051 US20250127725A1 (en) 2021-08-20 2022-08-09 Magnesium oxide tablets
PCT/JP2022/030484 WO2023022078A1 (ja) 2021-08-20 2022-08-09 酸化マグネシウム錠剤
TW111130617A TW202322827A (zh) 2021-08-20 2022-08-15 氧化鎂錠劑
JP2023087784A JP2023099857A (ja) 2021-08-20 2023-05-29 酸化マグネシウム錠剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2021134883A JP7340572B2 (ja) 2021-08-20 2021-08-20 酸化マグネシウム錠剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023087784A Division JP2023099857A (ja) 2021-08-20 2023-05-29 酸化マグネシウム錠剤

Publications (2)

Publication Number Publication Date
JP2023028906A JP2023028906A (ja) 2023-03-03
JP7340572B2 true JP7340572B2 (ja) 2023-09-07

Family

ID=85240721

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021134883A Active JP7340572B2 (ja) 2021-08-20 2021-08-20 酸化マグネシウム錠剤
JP2023087784A Pending JP2023099857A (ja) 2021-08-20 2023-05-29 酸化マグネシウム錠剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023087784A Pending JP2023099857A (ja) 2021-08-20 2023-05-29 酸化マグネシウム錠剤

Country Status (6)

Country Link
US (1) US20250127725A1 (enExample)
EP (1) EP4389133A4 (enExample)
JP (2) JP7340572B2 (enExample)
CN (1) CN117835990A (enExample)
TW (1) TW202322827A (enExample)
WO (1) WO2023022078A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7742381B2 (ja) * 2023-06-21 2025-09-19 セトラスホールディングス株式会社 錠剤の製造方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003146889A (ja) 2001-08-27 2003-05-21 Kyowa Chem Ind Co Ltd 制酸・緩下用錠剤
JP2010106014A (ja) 2008-10-01 2010-05-13 Taisho Pharmaceutical Co Ltd アセトアミノフェン含有錠剤
JP2010517936A (ja) 2007-02-01 2010-05-27 武田薬品工業株式会社 打錠障害を生じない錠剤製剤
WO2011030659A1 (ja) 2009-09-08 2011-03-17 協和化学工業株式会社 制酸・緩下用錠剤
WO2020101016A1 (ja) 2018-11-16 2020-05-22 協和化学工業株式会社 緩下用錠剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI564008B (zh) * 2010-09-30 2017-01-01 鹽野義製藥股份有限公司 難溶性藥物之溶解性改善製劑
US10166219B2 (en) * 2012-07-27 2019-01-01 Redhill Bipharma Ltd. Formulations and methods of manufacturing formulations for use in colonic evacuation
KR20150019620A (ko) * 2013-08-14 2015-02-25 삼성디스플레이 주식회사 유기발광 표시 장치
JP6182023B2 (ja) * 2013-08-30 2017-08-16 アサヒグループ食品株式会社 酸化マグネシウム含有錠剤及びその製造方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003146889A (ja) 2001-08-27 2003-05-21 Kyowa Chem Ind Co Ltd 制酸・緩下用錠剤
JP2010517936A (ja) 2007-02-01 2010-05-27 武田薬品工業株式会社 打錠障害を生じない錠剤製剤
JP2010106014A (ja) 2008-10-01 2010-05-13 Taisho Pharmaceutical Co Ltd アセトアミノフェン含有錠剤
WO2011030659A1 (ja) 2009-09-08 2011-03-17 協和化学工業株式会社 制酸・緩下用錠剤
WO2020101016A1 (ja) 2018-11-16 2020-05-22 協和化学工業株式会社 緩下用錠剤

Also Published As

Publication number Publication date
TW202322827A (zh) 2023-06-16
EP4389133A4 (en) 2025-07-30
US20250127725A1 (en) 2025-04-24
EP4389133A1 (en) 2024-06-26
WO2023022078A1 (ja) 2023-02-23
CN117835990A (zh) 2024-04-05
JP2023028906A (ja) 2023-03-03
JP2023099857A (ja) 2023-07-13

Similar Documents

Publication Publication Date Title
Ngwuluka et al. Formulation and evaluation of paracetamol tablets manufactured using the dried fruit of Phoenix dactylifera Linn as an excipient
SA08290401B1 (ar) تركيبات أقراص لاموتريجين تتفتت بالفم
JP5366233B2 (ja) 口腔内崩壊錠剤
JP5610865B2 (ja) 固形製剤
EP2476423A1 (en) Antacid and laxative tablet
JP4689468B2 (ja) 錠剤およびその製造方法
JPWO2017217491A1 (ja) 口腔内崩壊錠
JP7340572B2 (ja) 酸化マグネシウム錠剤
WO2020101016A1 (ja) 緩下用錠剤
KR100661782B1 (ko) 개선된 타정성을 갖는 정제 및 상기물의 제조 방법
JP2024050466A (ja) 固形組成物
JP3884056B1 (ja) 口腔内速崩錠の製造方法
JP5160156B2 (ja) 栄養機能食品錠剤
JP6341196B2 (ja) 固形製剤
JP2020509053A (ja) ピルフェニドンの粒子の大きさ調節による打錠性が改善された薬剤学的組成物およびその製造方法
JPWO2018021265A1 (ja) 口腔内崩壊錠添加用組成物
TWI637749B (zh) 以二階段濕式造粒步驟製造之崩解性粒子組成物及含有該組成物之口腔內崩解錠劑
JP2008037853A (ja) イソマルトを含有する速崩壊性医薬品固形製剤
JP6114573B2 (ja) ロキソプロフェンナトリウムと制酸剤を含有する固形製剤
WO2009151090A1 (ja) 炭酸カルシウム含有速崩壊性製剤
Jagtap et al. Development of directly compressible ascorbic acid tablet using novel excipients
EP1556050A1 (en) Pharmaceutical compositions of ganciclovir
JP6507547B2 (ja) 固形製剤
JP2008189634A (ja) 口腔内速崩錠の製造方法
JP2006022060A (ja) 制酸・緩下用水分散液およびそのための錠剤

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220721

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220927

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20221021

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20221125

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230111

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230328

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230529

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20230606

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20230707

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230828

R150 Certificate of patent or registration of utility model

Ref document number: 7340572

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150